Recent Finacing
Recent Raise
Immuno Cure develops PD-1-enhanced DNA vaccines (ICVAX HIV Phase I; ICCOV COVID-19 Phase IIa) and Anti-Δ42PD1 antibodies to restore T-cell function in liver and colorectal cancers.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor